检索结果-南通市图书馆

Extraintestinal manifestations in inflammatory bowel disease

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2005年第46期11卷 7227-7236页

作者： Silvio Danese Stefano Semeraro Alfredo Papa Italia Roberto Franco Scaldaferri Giuseppe Fedeli giovanni gasbarrini Antonio gasbarrini Department of Internal MedicineCatholic University School of Medicine L.go Vito 1Rome 00168Italy

Inflammatory bowel diseases (IBD) can be really considered to be systemic diseases since they are often associated with extraintestinal manifestations,complications, and other autoimmune disorders. Indeed,physicians who care for patients with ulcerative colitis and Crohn's disease, the two major forms of IBD, face a new clinical challenge every day, worsened by the very frequent rate of extraintestinal complications. The goal of this review is to provide an overview and an update on the extraintestinal complications occurring in ***, this paper highlights how virtually almost every organ system can be involved, principally eyes, skin,joints, kidneys, liver and biliary tracts, and vasculature (or vascular system) are the most common sites of systemic IBD and their involvement is dependent on different mechanisms.

关键词： Crohn's disease Ulcerative colitis Inflammatory bowel disease

Can chronic gastritis cause an increase in fecal calprotectin concentrations?

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2010年第27期16卷 3406-3410页

作者： Massimo Montalto Antonella Gallo Gianluca Ianiro Luca Santoro Ferruccio D Onofrio Riccardo Ricci giovanni Cammarota Marcello Covino Monica Vastola Antonio gasbarrini giovanni gasbarrini Ricca rdo Ricci Institute of Internal Medicine Catholic University Institute of Pathology Institute of Pa thology Catholic University00168RomeItaly

AIM:To evaluate fecal calprotectin concentrations(FCCs) in subjects with chronic gastritis and the correlation between FCCs and gastritis activity ***:FCCs were measured in 61 patients with histological diagnosis of gastritis and in 74 healthy *** grading of gastritis was performed according to the updated Sydney gastritis *** were subdivided into 2 groups according to the presence/absence of an active *** with chronic active gastritis were divided into 3 subgroups on the basis of the activity score(mild,moderate,marked).FFCs in relation to Helicobacter pylori(***) infection and proton pump inhibitor(PPI) use were also ***:FCCs in patients with chronic active gastritis were not significantly different to FCCs either in subjects with non active gastritis or in healthy *** patients with chronic active gastritis(even marked),FCCs did not significantly differ according to activity *** significant differences in FCCs were found when considering ***,as well as when considering PPI chronic ***:FCCs were not significantly increased in subjects with chronic gastritis,even in those patients with a marked neutrophil infiltration.

关键词： Chronic gastritis Fecal calprotectin Intestinal inflammation Neutrophils

Evaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2006年第16期12卷 2556-2562页

作者： giovanni gasbarrini Marcello Candelli RiccardoGiuseppe Graziosetto Sergio Coccheri Ferdinando Di Iorio Giuseppe Nappi Department of Internal medicine Catholic University of RomeItaly Department of Angiology University of BolognaItaly Department of Statistical Science and Biometry University of L'AquilaItaly Department of Thermal Medicine University of MilanItaly

AIM： To evaluate the efficacy of water supplementation treatment in patients with functional dyspepsia or irritable bowe syndrome （IBS） accompanying predominant constipation. METHODS： A total of 3872 patients with functional dyspepsia and 3609 patients with irritable bowel syndrome were enrolled in the study by 18 Italina thermal centres. Patients underwent a first cycle of thermal therapy for 21 d. A year later patients were re-evaluated at the same centre and received another cycle of thermal therapy. A questionnare to collect personal data on social and occupational status, family and pathological case history, life style, clinical records, utilisation of welfare and health structure and devices was administered to each patient at basal time and one year after each thermal treatment. Sixty patients with functional dyspepsia and 20 with IBS and 80 healthy controls received an evaluation of gastric output and oro-cecal transit time by breath test analysis. Breath test was performed at basal time and after water supplementaton therapies. Gastrointestinal symptoms were evaluated at the same time points. Breath samples were analyzed with a mass spectometer and a gascromatograph. Results were expressed as T1/2 and T-lag for octanoic add breath test and as oro-cecal transit time for lactulose breath test. RESULTS： A significant reduction of prevalence of symptoms was observed at the end of the first and second cycles of thermal therapy in dyspeptic and IBS patients, The analysis of variance showed a real and persistant improvement of symptoms in all patients. After water supplementation for 3 wk a reduction of gastric output was observed in 49 （87.5%） of 56 dyspepUc patients. Both T1/2 and T-lag were significantly reduced after the therapy compared to basal values [91 ± 12 （T1/2） and 53± 11 （T-lag）, Tables 1 and 2] with results of octanoic acid breath test similar to healthy subjects. After water supplementation for 3 wk oro-cecal transit time was shorter than that at t

关键词： Mineral water Constipation Dispepsia Thermal therapy

Origin of celiac disease:How old are predisposing haplotypes?

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第37期18卷 5300-5304页

作者： giovanni gasbarrini Olga Rickards Cristina Martínez-Labarga Elsa Pacciani Filiberto Chilleri Lucrezia Laterza Giuseppe Marangi Franco Scaldaferri Antonio gasbarrini Ricerca in Medicina Foundation NGO Falcone and Borsellino Gallery Center of Molecular Anthropology for Ancient DNA Studies Department of BiologyUniversity of Rome Tor Vergata Superintendence for the Archaeological Heritage of Tuscany Division of Gastroenterology Department Internal MedicineCatholic University of Sacred Heart Institute of Genetics Catholic University of Sacred Heart

We recently presented the case of a first century AD young woman, found in the archaeological site of Cosa, showing clinical signs of malnutrition, such as short height, osteoporosis, dental enamel hypoplasia and cribra orbitalia, indirect sign of anemia, all strongly suggestive for celiac disease (CD). However, whether these findings were actually associated to CD was not shown based on genetic parameters. To investigate her human leukocyte antigen (HLA) class Ⅱ polymorphism, we extracted DNA from a bone sample and a tooth and genotyped HLA using three HLA-tagging single nucleotide polymorphisms for DQ8, DQ2.2 and DQ2.5, specifically associated to CD. She displayed HLA DQ 2.5, the haplotype associated to the highest risk of CD. This isthe first report showing the presence of a HLA haplotype compatible for CD in archaeological specimens.

关键词： Celiac disease Human leukocyte antigen hap-Iotype Ancient DNA Single nucleotide polymorphisms Malabsorption

Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第36期18卷 5065-5071页

作者： Giuseppe Merra giovanni gasbarrini Lucrezia Laterza Marco Pizzoferrato Andrea Poscia Franco Scaldaferri Vincenzo Arena Francesca Fiore Achille Cittadini Alessandro Sgambato Francesco Franceschi Antonio gasbarrini Emergency Department Catholic University of Sacred Heart00168 RomeItaly Medical Research Foundation and nonprofit organization 40123 BolognaItaly Department of Internal Medicine and Gastroenterology Catholic University of Sacred Heart00168 RomeItaly Institute of Hygiene Catholic University of Sacred Heart00168 RomeItaly Institute of Pathology Catholic University of Sacred Heart00168 RomeItaly Department of Internal Medicine and Geriatry Catholic University of Sacred Heart00168 RomeItaly Institute of General Pathology Catholic University of Sacred Heart00168 RomeItaly

AIM:To assess clinical and endoscopic response to propionyl-L-carnitine hydrochloride(PLC) in colonic inflammatory bowel ***:Patients suffering from mild to moderate ulcerative colitis(UC) or Crohn's disease(CD) colitis,with disease activity index(DAI) between 3 and 10 and under stable therapy with oral aminosalicylates,mercaptopurine or azathioprine,for at least 8 wk prior to baseline assessments,were considered suitable for *** patients were enrolled to assume PLC 2 g/d(two active tablets twice daily) ***-endoscopic and histological activity were assessed by DAI and histological index(HI),respectively,following a colonoscopy performed immediately before and after 4 wk *** response was defined as a lowering of at least 3 points in DAI and clinical remission as a DAI score ≤ *** response was defined as an improvement of HI of at least 1 *** used median values for the *** pre-and post-treatment were analyzed by Wilcoxon signed rank ***:All patients enrolled completed the *** patient,despite medical advice,took deflazacort 5 d before follow-up colonoscopy *** side effects were reported by patients during the *** treatment,71%(SE 12%) of patients achieved clinical response,while 64%(SE 13%) obtained *** UC from CD patients,we observed a clinical response in 60%(SE 16%) and 100%,*** 60%(SE 16%) of UC patients and 75%(SE 25%) of CD patients were in clinical remission after *** median DAI was 7 [interquartile range(IQR):4-8] before treatment and decreased to 2(IQR:1-3)(P < 0.01) after *** patients with UC showed a significant reduction of DAI,from a median 6.5(IQR:4-9) before treatment to 2(IQR:1-3) after treatment(P < 0.01).Conversely,in CD patients,although displaying a clear reduction of DAI from 7(IQR:5.5-7.5) before therapy to 1.5(IQR:0.5-2.5) after therapy,differences observed were not sign

关键词： PropionyI-L-carnitine Ulcerative colitis Crohn's disease Inflammatory bowel disease therapy PropionyI-L-carnitine hydrochloride

Gut microbiota in autism and mood disorders

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2016年第1期22卷 361-368页

作者： Francesca Mangiola Gianluca Ianiro Francesco Franceschi Stefano Fagiuoli giovanni gasbarrini Antonio gasbarrini Catholic University School of Medicine00168 RomeItaly Department of Internal Medicine Division of Internal MedicineGastroenterology and Liver Disease “A.Gemelli”University Hospital 00168 RomeItaly Gastroenterology and Transplant Hepatology Papa Giovanni XXIII Hospital24127 BergamoItaly “Ricerca in Medicina”ONLUS Foundation 40121 BolognaItaly

The hypothesis of an important role of gut microbiota in the maintenance of physiological state into the gastrointestinal(GI)system is supported by several studies that have shown a qualitative and quantitative alteration of the intestinal flora in a number of gastrointestinal and extra-gastrointestinal *** the last few years,the importance of gut microbiota impairment in the etiopathogenesis of pathology such as autism,dementia and mood disorder,has been *** evidence of the inflammatory state alteration,highlighted in disorders such as schizophrenia,major depressive disorder and bipolar disorder,strongly recalls the microbiota alteration,highly suggesting an important role of the alteration of GI system also in neuropsychiatric *** to now,available evidences display that the impairment of gut microbiota plays a key role in the development of autism and mood *** application of therapeutic modulators of gut microbiota to autism and mood disorders has been experienced only in experimental settings to date,with few but promising results.A deeper assessment of the role of gut microbiota in the development of autism spectrum disorder(ASD),as well as the advancement of the therapeutic armamentarium for the modulation of gut microbiota is warranted for a better management of ASD and mood disorders.

关键词： Gut microbiota Mood disorders Autism Depression Gut microbiota modulation Fecal microbiotatransplantation

Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Transplantation 2024年第2期14卷 99-106页

作者： Marco Biolato Luca Miele Giuseppe Marrone Claudia Tarli Antonio Liguori Rosaria Calia giovanni Addolorato Salvatore Agnes Antonio gasbarrini Maurizio Pompili Antonio Grieco Department of Medical and Surgical Sciences CEMADFondazione Policlinico Universitario Agostino Gemelli IRCCSRome 00168Italy Department of Translational Medicine and Surgery Catholic University of Sacred HeartRome 00168Italy

BACKGROUND Few studies have evaluated the frequency of and the reasons behind the refusal of listing liver transplantation *** To assess the ineligibility rate for liver transplantation and its *** A single-center retrospective study was conducted on adult patients which entailed a formal multidisciplinary assessment for liver transplantation *** predictors for listing were evaluated using multivariable logistic *** In our center,314 patients underwent multidisciplinary work-up before liver transplantation enlisting over a three-year *** most frequent reasons for transplant evaluation were decompensated cirrhosis(51.6%)and hepatocellular carcinoma(35.7%).The non-listing rate was 53.8%and the transplant rate was 34.4%for the whole *** hundred and five motivations for ineligibility were *** most common contraindications were psychological(9.3%),cardiovascular(6.8%),and surgical(5.9%).Inappropriate or premature referral accounted for 76(37.1%)*** multivariable analysis,a referral from another hospital(OR:2.113;95%CI:1.259–3.548)served as an independent predictor of *** A non-listing decision occurred in half of our cohort and was based on an inappropriate or premature referral in one case out of *** referral from another hospital was taken as a strong predictor of non-listing.

关键词： Controindication Eligibility Evaluation Referral Personalized medicine

Colon cancer stem cells:Controversies and perspectives

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2013年第20期19卷 2997-3006页

作者： Maria Ausiliatrice Puglisi Valentina Tesori Wanda Lattanzi giovanni Battista gasbarrini Antonio gasbarrini Department of Internal Medicine and Gastroenterology Gemelli Hospital00168 RomeItaly Institute of Anatomy and Cell Biology Università Cattolica del Sacro Cuore00168 RomeItaly Fondazione Ricerca in Medicina ONLUS 40123 BolognaItaly

Tumors have long been viewed as a population in which all cells have the equal propensity to form new tumors,the so called conventional stochastic *** cutting-edge theory on tumor origin and progression,tends to consider cancer as a stem cell *** cells are actively involved in the onset and maintenance of colon *** review is intended to examine the state of the art on colon cancer stem cells(CSCs),with regard to the recent achievements of basic research and to the corresponding translational *** prominence is given to the hypothesized origin of CSCs and to the methods for their *** growing understanding of CSC biology is driving the optimization of novel anti-cancer targeted drugs.

关键词： Colon cancer stem cells Colorectal cancer CD133 Therapy Chemoresistance

Gut microbiome beats two to zero host genome

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Hepatobiliary Surgery and Nutrition 2019年第4期8卷 378-380页

作者： giovanni Cammarota Lorenza Putignani Antonio gasbarrini Department of Gastroenterology Catholic UniversitySchool of Medicine and SurgeryA.Gemelli HospitalRomeItaly Parasitology and Human Microbiome Units “Bambino Gesu”Children’s HospitalIRCCSRomeItaly Digestive Disease Center Fondazione Policlinico Gemelli IRCCSUniversitàCattolica del Scaro CuoreRomaItaly

The gut microbiota and its genomic scaffold, exceeding the human one nearly 500 times, substantially affect human health and diseases. Host-microbe interactions, exerted through microbial biochemical and immunological activities, contain pathogen burden, control neurological and endocrine signalling, enterocyte wellness, energy biosynthesis, gut dysbiosis, complement gaps of host metabolic pathways, finally contributing to human physiology and disease within the gastrointestinal district and through gut-liver and gut-brain axis (1). Regardless substantial advances in correlating microbiota modulation and perturbation with various influencers, the specific impact of internal and external stimuli need to be definitely assigned though causality relationships beyond correlative measures. Host origin or genetic background, age, sanitation, delivery mode, breast-feeding and weaning, infections, diet, drugs, but also exercise, sleep, stress have been reviewed in a wide range of recent literature (2). All external (i.e., food, pathogens) and internal (i.e., microbiota) host modulating factors, both, can be conceptually synthetized by the term "exposome" which we are exposed to in the lifetime and which drives both individual enterophenotypes and disease phenotypes (3). Integrative descriptive and functional charts of microbiota allow the description of the microbiota-host Holobionts system, relationship that can be employed in understanding personalized physiology and nutrition, thus providing patient-tailored therapies (Figure 1). To investigate microbiota unbalance and passage from healthy to disease or unhealthy status, individual baseline compositions and variations within an individual's own range are required.

关键词： Figure exceeding passage